Vanguard Group’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Hold |
1,056,922
| – | – | ﹤0.01% | 3321 |
|
|
2025
Q1 | $1.61M | Hold |
1,056,922
| – | – | ﹤0.01% | 3563 |
|
|
2024
Q4 | $2.33M | Sell |
1,056,922
-13,400
| -1% | -$29.5K | ﹤0.01% | 3521 |
|
|
2024
Q3 | $2.67M | Hold |
1,070,322
| – | – | ﹤0.01% | 3468 |
|
|
2024
Q2 | $1.37M | Sell |
1,070,322
-133,344
| -11% | -$171K | ﹤0.01% | 3691 |
|
|
2024
Q1 | $3.48M | Buy |
1,203,666
+129,851
| +12% | +$375K | ﹤0.01% | 3426 |
|
|
2023
Q4 | $7.89M | Buy |
1,073,815
+29,963
| +3% | +$220K | ﹤0.01% | 3078 |
|
|
2023
Q3 | $8.02M | Buy |
1,043,852
+42,722
| +4% | +$328K | ﹤0.01% | 3010 |
|
|
2023
Q2 | $10.2M | Buy |
1,001,130
+125,162
| +14% | +$1.27M | ﹤0.01% | 2933 |
|
|
2023
Q1 | $8.51M | Buy |
875,968
+38,289
| +5% | +$372K | ﹤0.01% | 3021 |
|
|
2022
Q4 | $4.06M | Buy |
837,679
+19,190
| +2% | +$93.1K | ﹤0.01% | 3399 |
|
|
2022
Q3 | $11.7M | Buy |
818,489
+77,866
| +11% | +$1.12M | ﹤0.01% | 2875 |
|
|
2022
Q2 | $4.01M | Sell |
740,623
-71,769
| -9% | -$388K | ﹤0.01% | 3493 |
|
|
2022
Q1 | $5.26M | Buy |
812,392
+498,479
| +159% | +$3.23M | ﹤0.01% | 3503 |
|
|
2021
Q4 | $5.08M | Sell |
313,913
-29,688
| -9% | -$480K | ﹤0.01% | 3600 |
|
|
2021
Q3 | $9.12M | Buy |
+343,601
| New | +$9.12M | ﹤0.01% | 3292 |
|